Pain Quality by Location in Outpatients with Cancer
- PMID: 31160180
- PMCID: PMC6875614
- DOI: 10.1016/j.pmn.2019.04.007
Pain Quality by Location in Outpatients with Cancer
Abstract
Background: The McGill Pain Questionnaire (MPQ) pain quality descriptors have been analyzed to characterize the sensory, affective, and evaluative domains of pain, but have not been differentiated by pain location.
Aim: To examine MPQ pain quality descriptors by pain location in outpatients with lung or prostate cancer.
Design: Cross sectional.
Settings: Eleven oncology clinics or patients' homes.
Subjects: 264 adult outpatients (80% male; mean age 62.2 ± 10.0 years, 85% White).
Methods: Subjects completed a 100 mm visual analogue scale of pain intensity and MPQ clinic or home visit, marking sites where they had pain on a body outline and circling from 78 verbal descriptors those that described their pain. A researcher noted next to the descriptor spontaneous comments about sites feeling like a selected word and queried the subjects about any other words to obtain the site(s).
Results: Pain quality descriptors were assigned to all 7 pain locations marked by ≥ 20% of 198 lung or 66 prostate cancer patients. Four pain locations were marked with pain quality descriptors significanlty (p < .05) more frequently for lung cancer (53% chest-aching, burning; 58% back-aching, stabbing; 48% head-aching, sharp; and 19% arms-aching, stabbing) than for prostate cancer, which had significantly more frequent pain locations in the abdomen (64%-aching, burning) and lower back/buttocks (55%-aching, burning).
Conclusions: This type of pain characterization is innovative and has the potential to help implement targeted treatments for patients with cancer and other chronic pain conditions.
Copyright © 2019 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Similar articles
-
The use of pain descriptors in cancer patients.J Pain Symptom Manage. 2009 Aug;38(2):208-15. doi: 10.1016/j.jpainsymman.2008.08.008. Epub 2009 Mar 28. J Pain Symptom Manage. 2009. PMID: 19328649
-
Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors.J Pain Symptom Manage. 2001 Nov;22(5):899-910. doi: 10.1016/s0885-3924(01)00351-7. J Pain Symptom Manage. 2001. PMID: 11728793 Free PMC article. Clinical Trial.
-
Nonmalignant chronic pain evaluation in the Turkish population as measured by the McGill Pain Questionnaire.Pain Pract. 2007 Sep;7(3):265-73. doi: 10.1111/j.1533-2500.2007.00141.x. Pain Pract. 2007. PMID: 17714106
-
Assessment of adult cancer pain: shortcomings of current methods.Pain. 1988 Feb;32(2):133-139. doi: 10.1016/0304-3959(88)90061-9. Pain. 1988. PMID: 3283659 Review.
-
The McGill Pain Questionnaire as a multidimensional measure in people with cancer: an integrative review.Pain Manag Nurs. 2012 Mar;13(1):27-51. doi: 10.1016/j.pmn.2010.12.003. Epub 2011 May 20. Pain Manag Nurs. 2012. PMID: 22341138 Free PMC article. Review.
Cited by
-
Distinct Worst Pain Profiles in Oncology Outpatients Undergoing Chemotherapy.Cancer Nurs. 2023 May-Jun 01;46(3):176-188. doi: 10.1097/NCC.0000000000001095. Epub 2022 Dec 10. Cancer Nurs. 2023. PMID: 35439202 Free PMC article.
-
Sociodemographic and Clinical Characteristics Associated With Worst Pain Intensity Among Cancer Patients.Pain Manag Nurs. 2022 Aug;23(4):424-429. doi: 10.1016/j.pmn.2021.11.006. Epub 2022 Feb 25. Pain Manag Nurs. 2022. PMID: 35227646 Free PMC article.
-
To Explore the Effects of Acupuncture and Medical Treatment at Different Times on the Gastrointestinal Reaction and White Blood Cell Count of Patients with Lung Cancer Chemotherapy.Appl Bionics Biomech. 2022 Apr 7;2022:5261344. doi: 10.1155/2022/5261344. eCollection 2022. Appl Bionics Biomech. 2022. Retraction in: Appl Bionics Biomech. 2023 Mar 9;2023:9892836. doi: 10.1155/2023/9892836. PMID: 35432592 Free PMC article. Retracted.
-
Risk factors for chronic postsurgical pain following thoracoscopic surgery for lung cancer.Am J Transl Res. 2024 Dec 15;16(12):7959-7971. doi: 10.62347/NHTK3687. eCollection 2024. Am J Transl Res. 2024. PMID: 39822545 Free PMC article.
-
Immunotherapy improved cancer related pain management in patients with advanced Hepato-Pancreatic Biliary Cancers: A propensity score-matched (PSM) analysis.Front Oncol. 2022 Sep 21;12:914591. doi: 10.3389/fonc.2022.914591. eCollection 2022. Front Oncol. 2022. PMID: 36212482 Free PMC article.
References
-
- Ahles TA, Blanchard EB, & Ruckdeschel JC (1983). The multidimensional nature of cancer-related pain. PAIN, 17(3), 277–288. - PubMed
-
- Arner S, & Arner B (1985). Differential Effects of Epidural Morphine in the Treatment of Cancer-related Pain. Acta Anaesthesiologica Scandinavica, 29(1), 32–36. - PubMed
-
- Arner S, & Meyerson BA (1988). Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. PAIN, 33(1), 11–23. - PubMed
-
- Beckles MA, Spiro SG, Colice GL, & Rudd RM (2003). Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest, 123(1 Suppl), 97s–104s. - PubMed
-
- Berry DL, Wilkie DJ, Huang HY, & Blumenstein BA (1999). Cancer pain and common pain: a comparison of patient-reported intensities. Oncology Nursing Forum, 26(4), 721–726. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical